Written by: Kirollos S. Hanna, PharmD, BCPS, BCOP – University of Minnesota Medical Center & Mayo Clinic
Download Here

This PQI will discuss optimal prevention and control of CINV which has been associated with improved adherence to oncolytic therapy.
Continue reading Chemotherapy-Induced Nausea and Vomiting

Read More

Written by: Natasha Heimbigner, PharmD, Summit Cancer Centers
Download Here

Proper prevention and management of immunotherapy related rash is an important intervention for the patient’s quality of life and continuation of therapy. Continue reading Managing Immunotherapy Treatment Related Rash

Read More

Written by: Michelle Phillips, PharmD, University of Rochester Medical Center
Download Here

The purpose of this PQI is to highlight key criteria for appropriate monitoring, dosing, and administration to improve the dispensing and management of patients taking niraparib (Zejula).

Continue reading Niraparib: dose modifications based on weight and platelet counts

Read More